Zhiwei Xie

Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial

Yueping Li, Zhiwei Xie, Weiyin Lin et al. · Med · 2020 · 301 citations · Full text

Adult Patients, Covid-19 Pandemic, Antiviral Drug Development +9

An exploratory randomized controlled study on the efficacy and safety of lopinavir/ritonavir or arbidol treating adult patients hospitalized with mild/moderate COVID-19 (ELACOI)

Yueping Li, Zhiwei Xie, Weiyin Lin et al. · 2020 · 143 citations · Full text

Pharmacotherapy, Covid-19 Epidemiology, Antiviral Drug +16

Application of Metagenomic Next-Generation Sequencing (mNGS) Using Bronchoalveolar Lavage Fluid (BALF) in Diagnosing Pneumonia of Children

Aimei Yang, Chen Chen, Yan Hu et al. · Microbiology Spectrum · 2022 · 87 citations · Full text

HpoR, a novel c-di-GMP effective transcription factor, links the second messenger’s regulatory function to the mycobacterial antioxidant defense

Weihui Li, Meng Li, Lihua Hu et al. · Nucleic Acids Research · 2018 · 59 citations · Full text

Molecular Biology, Second Messenger ’, Cyclic Di-gmp +17

Clinical Characteristics of Patients Infected With the Novel 2019 Coronavirus (SARS-Cov-2) in Guangzhou, China

Yaping Wang, Baolin Liao, Yan Guo et al. · Open Forum Infectious Diseases · 2020 · 56 citations · Full text